The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study

Kubota, ChikaChikaKubotaInada, ToshiyaToshiyaInadaLin, Shih-KuShih-KuLinAvasthi, AjitAjitAvasthiChee, Kok YoonKok YoonCheeTanra, Andi JayalangkaraAndi JayalangkaraTanraYang, Shu-YuShu-YuYangLIAN-YU CHENChong, Mian-YoonMian-YoonChongTripathi, AdarshAdarshTripathiKallivayalil, Roy AbrahamRoy AbrahamKallivayalilGrover, SandeepSandeepGroverPark, Seon-CheolSeon-CheolParkKato, Takahiro ATakahiro AKatoXiang, Yu-TaoYu-TaoXiangSim, KangKangSimMaramis, Margarita MMargarita MMaramisNoor, Isa MultazamIsa MultazamNoorTan, Chay-HoonChay-HoonTanSartorius, NormanNormanSartoriusShinfuku, NaotakaNaotakaShinfuku2023-02-102023-02-102022-12-0308856222https://scholars.lib.ntu.edu.tw/handle/123456789/627892Drug-induced extrapyramidal syndrome (EPS) remains a major problem in clinical psychiatry. This study aimed to examine the factor structure of drug-induced extrapyramidal symptoms observed in patients with schizophrenia and assessed using the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS).enDIEPSS; antipsychotics; extrapyramidal symptoms; schizophreniaThe factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 studyjournal article10.1002/hup.2861364621842-s2.0-85143831632https://api.elsevier.com/content/abstract/scopus_id/85143831632